For US residents only.


Zero in on what may make your metastatic non-small cell lung cancer unique

A comprehensive biomarker test can help you and your doctor zero in on the right metastatic non-small cell lung cancer (mNSCLC) treatment for you.


Comprehensive Biomarker Testing for mNSCLC

Ask your doctor to test for different traits of your specific type of cancer, such as PD-L1 levels or mutations like EGFR, ALK, and METex14.


ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; MET,  mesenchymal-epithelial transition; METex14, MET exon 14 skipping; PD-L1,  programmed death-ligand 1.

Find the right treatment for you

Your test results may help your doctor find a treatment path specific to your mNSCLC, whether it includes targeted therapy or not.





Use of website is governed by the Terms of Use and Privacy Policy.

Copyright © 2021 Novartis Pharmaceuticals Corporation. All rights reserved.

8/21 142273